Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  2, 405 - 411 (1996)
doi:10.1038/nm0496-405

Influence of combinations of human major histocompatibility complex genes on the course of HIV−1 infection

R.A. Kaslow1, 10, M. Carrington2, R. Apple3, L. Park4, A. Muñoz4, A.J. Saah4, J.J. Goedert5, C. Winkler2, S.J. O'Brien6, C. Rinaldo7, R. Detels8, W. Blattner5, J. Phair9, H. Erlich3 & D.L. Mann6

  1University of Alabama at Birmingham, School of Public Health, Department of Epidemiology, 212C Tidwell Hall, 720 20th Street South, Birmingham, Alabama 35294-0008, USA

  2BCDP-SAIC, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201, USA

  3Human Genetics Department, Roche Molecular Systems, Inc., Alameda, California 94501, USA

  4Department of Epidemiology, the Johns Hopkins School of Hygiene and Public Health, 624 North Broadway, Baltimore, Maryland 21205, USA

  5Viral Epidemiology Branch, Division of Cancer Etiology, National Cancer Institute, EPN Room 434, 6130 Executive Boulevard, Rockville, Maryland 20852-7370, USA

  6Laboratory of Viral Carcinogenesis, Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201, USA

  7Department of Pathology, University of Pittsburgh, 130 DeSoto Street, Pittsburgh, Pennsylvania 15261, USA

  8Department of Epidemiology, UCLA School of Public Health, Center for the Health Sciences Room 71-267,10833 Le Conte Avenue, Los Angeles, California 90024-1772, USA

  9Department of Medicine, Northwestern Medical School, Comprehensive AIDS Center, 680 North Lake Shore Drive, Suite 1106, Chicago, Illinois 60611-4402, USA

  10Correspondence should be addressed to R.A.K.

Major histocompatibility complex (MHC) genes (HLA in humans) regulate the immune response to foreign antigens. Molecular and serologic techniques were used to identify products of HLA class I, class II and transporter (TAP) genes (also part of the MHC) in homosexual seroconverters to human immunodeficiency virus type 1 (HIV−1). Comprehensive statistical analysis produced an HLA profile that predicted time from HIV−1 infection to the onset of AIDS. The profile was developed in a cohort of 139 men and evaluated in a second unrelated cohort of 102 men. In the evaluation cohort, the profile discriminated a sixfold difference between groups with the shortest and longest times to AIDS (P = 0.001). These findings support current theory about control of antigen processing by HLA genes and have implications for immunopathogenesis of HIV−1 and other infections.

REFERENCES
  1. Schrager, L.K., Young, J.M., Fowler, M.G., Mathieson, B.J. & Vermund, S.H. Long-term survivors of HIV infection. Acquir. Immune Defic. Syndr. 8 (suppl. 1), S95−S108 (1994).
  2. Phair, J. et al. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: The Multicenter AIDS Cohort Study. J. Acquir. Immune. Defic. Syndr. 5, 490−496 (1992). | PubMed  | ISI | ChemPort |
  3. Keet, I.P.M. et al. Characteristics of long-term asymptomatic human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts. J. Infect. Dis. 169, 1236−1243 (1994). | PubMed  | ISI | ChemPort |
  4. Munoz, A. et al. Long term survivors with HIV-1 infection: Incubation period and longitudinal patterns of CD4+ lymphocytes. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 8, 496−505 (1995). | ChemPort |
  5. Hessol, N.A. et al. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978−1991. Am. J. Epidemiol. 139, 1077−1087 (1994). | PubMed  | ISI | ChemPort |
  6. Alcabes, P., Munoz, A., Vlahov, D. & Friedland, G.H. Incubation period of human immunodeficiency virus. Epidemiol. Rev. 15, 303−318 (1993). | PubMed  | ISI | ChemPort |
  7. Rosenberg, P.S., Goedert, J.J. & Biggar, R.J. Effect of age at seroconversion on the natural AIDS incubation distribution: Multicenter hemophilia cohort study and the international registry of seroconverters. Acquir. Immune. Defic. Syndr. 8, 803−810 (1994). | ChemPort |
  8. Ashton, L.J., Learmont, J., Luo, K., Wylie, B. & Stewart, G. HIV infections in recipients of blood products from donors with known duration of infection. Lancet 344, 718−720 (1994). | Article | PubMed  | ISI | ChemPort |
  9. Rezza, G. et al. in HIV Epidemiology: Models and Methods. (ed. Nicolosi, A.) 279−291 (Raven, New York, 1994).
  10. Centers for Disease Control, Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Morbid. Mortal. Weekly Rep. 36 (1S) 3S−15S (1987).
  11. Townsend, A. et al. Assembly of MHC class I molecules analyzed in vitro. Cell 62, 285−295 (1990). | Article | PubMed  | ISI | ChemPort |
  12. Schumacher, T.N.M. et al. Peptide selection by MHC class-I molecules. Cell 62, 563−567 (1990). | Article | PubMed  | ISI | ChemPort |
  13. Kelly, A. et al. Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 355, 641−644 (1992). | Article | PubMed  | ISI | ChemPort |
  14. Spies, T. et al. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature 355, 644−646 (1992). | Article | PubMed  | ISI | ChemPort |
  15. Klein, M.R. et al. Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181, 1365−1372 (1995). | PubMed  | ISI | ChemPort |
  16. Rowland-Jones, S. et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med. 1, 59−64 (1995). | PubMed  |
  17. Becker, Y. HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses. Virus Genes 8, 249−270 (1994). | PubMed  | ISI | ChemPort |
  18. Doherty, P.C. & Zinkernagel, R.M. A biological role for the major histocompatibility antigens. Lancet 1, 1406−1409 (1975). | Article | PubMed  | ISI | ChemPort |
  19. Dupont, B. (ed.) Immunobiology of HLA. (Springer, New York, 1989).
  20. Tiwari, J. & Terasaki, P. (eds.) HLA and Disease Associations. 383−400 (Springer, New York, 1985).
  21. Hill, A.V.S. et al. Common West African HLA antigens are associated with protection from severe malaria. Nature 352, 595−600 (1991). | Article | PubMed  | ISI | ChemPort |
  22. Kroner, B.L., Goedert, J.J., Carrington, M., Mann, D.L. & Blattner, W.A. Concordance of haplotype sharing, CD4 decline and AIDS in hemophilic sibling pairs. Acquir. Immune Defic. Syndr. 9, 275−280 (1995). | ChemPort |
  23. Keet, I.P.M., Klein, M.R., Just, J.J. & Kaslow, R.A. The role of host genetics in the natural history of HIV-1 infection: The needles in the haystack. Acquir. Immun. Defic. Syndr. Hum. Retrovir. (in the press).
  24. Mann, D.L., Carrington, M.N. & Kroner, B.L. The human major histocompatibility complex in HIV-1 pathogenesis. Acquir. Immune Defic. Syndr. 8 (suppl. 1), S53−S60 (1994).
  25. Kaslow, R.A. & Mann, D. The role of the major histocompatibility complex in human immunodeficiency virus infection — ever more complex?. J. Infect. Dis. 169, 1332−1333 (1994). | PubMed  | ISI | ChemPort |
  26. Fukuda, K. et al. Statistical detection of HLA and disease association. Tissue Antigens 26, 81−86 (1985). | PubMed  | ISI | ChemPort |
  27. Klitz, W., Thomson, G., Borot, N. & Cambon-Thomsen, A. in Evolutionary Biology, Volume 26. (ed. Hecht, M.K.) 35−72 (Plenum, New York, 1992). | ChemPort |
  28. Thursz, M.R. et al. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N. Engl. J. Med. 332, 1065−1069 (1995). | Article | PubMed  | ISI | ChemPort |
  29. Phillips, R.E. et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T-cell recognition. Nature 354, 453−459 (1991). | Article | PubMed  | ISI | ChemPort |
  30. Kubo, R.T. et al. Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol. 152, 3913−3924 (1994). | PubMed  | ISI | ChemPort |
  31. Fukazawa, T. et al. Testing the importance of each residue in a HLA-B27-binding peptide using monoclonal antibodies. J. Immunol. 152, 1190−1196 (1994). | PubMed  | ISI | ChemPort |
  32. Goedert, J.J. et al. Decreased helper T lymphocytes in homosexual men. I. Sexual contact in high incidence areas for the acquired immunodeficiency syndrome. Am. J. Epidemiol. 121, 629−636 (1985). | PubMed  | ISI | ChemPort |
  33. Kaslow, R.A. et al. The Multicenter AIDS Cohort Study: Rationale, organization and selected characteristics of the participants. Am. J. Epidemiol. 126, 310−318 (1987). | PubMed  | ISI | ChemPort |
  34. Amos, D.B., Pool, P. & Grier, J. in Manual of Clinical Immunology. (eds. Rose, N. & Friedman, H.) 978−986 (American Society for Microbiology, Washington, 1980).
  35. Erlich, H.A. & Bugawan, T.L. in PCR Technology: Principles and applications for DNA Amplification. (ed. Erlich, H.A.) 193−208 (Stockton, New York, 1989).
  36. Carrington, M. et al. Typing of HLA-DQA1 and DQB1 using DNA single-strand conformation polymorphism. Hum. Immunol. 33, 208−212 (1992). | Article | PubMed  | ISI | ChemPort |
  37. Bannai, M. et al. Discrimination of human HLA-DRB1 alleles by PCR-SSCP (single-strand conformation polymorphism) method. Eur. J. Immunogenetics 21, 1−9 (1994). | ISI | ChemPort |
  38. Carrington, M., Colonna, M., Spies, T., Stephens, J.C. & Mann, D.L. Haplotypic variation of the transporter associated with antigen processing (TAP) genes and their extension of HLA class II region haplotypes. Immunogenetics 37, 266−273 (1993). | PubMed  | ISI | ChemPort |
  39. PHREG, SAS Release 6.09, SAS Institute, Inc., Gary, North Carolina.
  40. Munoz, A. & Townsend, T.R. in Prevention and Control of Nosocomial Infection. 2nd edn. (ed. Wenzel, R.) (Williams and Wilkins, Baltimore, Maryland, 1993).
  41. Miller, R.G. Survival Analysis. (Wiley, New York, 1981).
  42. Begovich, A. et al. Polymorphism, recognition and linkage disequilibrium within the HLA class II region. J. Immunol. 148, 249−258 (1992). | PubMed  | ISI | ChemPort |
  43. Carrington, M. et al. Major histocompatibility complex class II haplotypes and linkage disequilibrium values observed in the CEPH families. Hum. Immunol. 41, 234−240 (1994). | Article | PubMed  | ISI | ChemPort |
 Top
 Top
Abstract
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1996 Nature Publishing Group | Privacy policy